The SANAD II study of the Effectiveness and Cost-Effectiveness of Levetiracetam, Zonisamide, or Lamotrigine for Newly Diagnosed Focal Epilepsy: An Open-Label, Non-Inferiority, Multicentre, Phase 4, Randomised Controlled Trial
Lancet 397:1363-1374, Marson, A.,et al, 2021
The SANAD Study of Effectiveness of Carbamazepine,Gabapentin,Lamotrigine,Oxcarbazepine,or Topiramate for Treatment of Partial Epilepsy:An Unblinded Randomised Controlled Trial
Lancet 369:1000-1015, Marson,A.G.,et al, 2007
Lamotrigine Extended-Release as Adjunctive Therapy for Partial Seizures
Neurol 69:1610-1618, Naritoku,D.K.,et al, 2007
Symptomatic SUNCT in an Eleven-Year-Old Girl
Neurol 60:2012-2013, Blattler,T.,et al, 2003
Possible Usefulness of Lamotrigine in the Treatment of SUNCT Syndrome
Neurol 53:1609, D'Andrea,G.,et al, 1999
An Active-Control Trial of Lamotrigine Monotherapy for Partial Seizures
Neurol 51:1018-1025,940, Gilliam,F.,et al, 1998
Placebo-Controlled Study of the Efficacy and Safety of Lamotrigine in Patients with Partial Seizures
Neurol 43:2284-2291, Matsuo,F.,et al, 1993